A detailed history of Black Rock Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 15,683,206 shares of ARWR stock, worth $305 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,683,206
Previous 15,346,637 2.19%
Holding current value
$305 Million
Previous $439 Million 7.13%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$21.87 - $28.24 $7.36 Million - $9.5 Million
336,569 Added 2.19%
15,683,206 $408 Million
Q1 2024

May 10, 2024

BUY
$27.21 - $39.48 $55.6 Million - $80.7 Million
2,042,880 Added 15.36%
15,346,637 $439 Million
Q4 2023

Feb 13, 2024

BUY
$21.2 - $31.03 $9.84 Million - $14.4 Million
464,263 Added 3.62%
13,303,757 $407 Million
Q3 2023

Nov 13, 2023

BUY
$26.2 - $36.08 $742,403 - $1.02 Million
28,336 Added 0.22%
12,839,494 $345 Million
Q2 2023

Aug 11, 2023

BUY
$25.16 - $41.38 $2.52 Million - $4.15 Million
100,357 Added 0.79%
12,811,158 $457 Million
Q1 2023

May 12, 2023

SELL
$23.68 - $38.51 $7,980 - $12,977
-337 Reduced -0.0%
12,710,801 $323 Million
Q4 2022

Feb 13, 2023

BUY
$28.0 - $40.56 $17.4 Million - $25.3 Million
623,050 Added 5.15%
12,711,138 $516 Million
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $5.82 Million - $9.49 Million
-196,385 Reduced 1.6%
12,088,088 $400 Million
Q2 2022

Aug 12, 2022

BUY
$27.79 - $50.61 $3.6 Million - $6.55 Million
129,389 Added 1.06%
12,284,473 $433 Million
Q1 2022

May 12, 2022

BUY
$39.62 - $69.97 $5.82 Million - $10.3 Million
147,021 Added 1.22%
12,155,084 $559 Million
Q4 2021

Feb 10, 2022

BUY
$58.09 - $82.51 $3.85 Million - $5.46 Million
66,218 Added 0.55%
12,008,063 $796 Million
Q3 2021

Nov 09, 2021

SELL
$58.38 - $84.96 $12.1 Million - $17.6 Million
-207,658 Reduced 1.71%
11,941,845 $746 Million
Q2 2021

Aug 11, 2021

BUY
$62.15 - $90.32 $755 Million - $1.1 Billion
12,149,503 New
12,149,503 $1.01 Billion

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.06B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.